Bispecific antibody drug conjugates: Making 1+1>2
Bispecific antibody‒drug conjugates (BsADCs) represent an innovative therapeutic category amalgamating the merits of antibody‒drug conjugates (ADCs) and bispecific antibodies (BsAbs). Positioned as the next-generation ADC approach, BsADCs hold promise for ameliorating extant clinical challenges asso...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2024-05-01
|
| Serier: | Acta Pharmaceutica Sinica B |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2211383524000121 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
